Skip to main content

Advertisement

ADVERTISEMENT

Volume 8 - Issue 12 - December, 2000

Feature

Review
12/04/2008
1Thomas J. Kiernan, MD, 2,3Andrew E. Ajani, MBBS, MD, 1Bryan P. Yan, MBBS 1Cardiology Division, Section of Vascular Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, 2Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia, 3University of Melbourne, Melbourne, Victoria, Australia.
1Thomas J. Kiernan, MD, 2,3Andrew E. ...
Abstract: The role of endovascular therapy for the treatment of coronary and peripheral vascular diseases (including carotid, renal and lower extremity arteries) is expanding. The steady growth in the volume of endovascular procedures is...
Abstract: The role of endovascular therapy for the treatment of coronary and peripheral vascular diseases (including carotid, renal and lower extremity arteries) is expanding. The steady growth in the volume of endovascular procedures is...
Abstract: The role of...
12/04/2008
Cath Lab Digest
06/19/2008

Thomas J. Ryan, M.D. Professor of Medicine and Chief, Emeritus, Section of Cardiology, Boston Medical Center, Boston MA

Thomas J. Ryan, M.D. Professor of Med...
In an effort to maintain a balanced national sense on this issue that has cardiologists divided in their opinions, it seems critically important to make the nurses, technicians and other healthcare professionals who constitute the...
In an effort to maintain a balanced national sense on this issue that has cardiologists divided in their opinions, it seems critically important to make the nurses, technicians and other healthcare professionals who constitute the...
In an effort to maintain a...
06/19/2008
Cath Lab Digest
06/19/2008

Nancy Sinclair McNamara, RN, BSN, Thomas P. Wharton Jr., MD, FACC, Division of Cardiovascular Services, Exeter Hospital, Exeter, New Hampshire

Nancy Sinclair McNamara, RN, BSN, Tho...
Primary PTCA vs. Fibrinolytic Therapy Dr. Ryan™s contention that there is no conclusive evidence that primary PTCA is superior to fibrinolytic therapy in acute myocardial infarction (AMI) is counter to a large volume of literature1-4 (see...
Primary PTCA vs. Fibrinolytic Therapy Dr. Ryan™s contention that there is no conclusive evidence that primary PTCA is superior to fibrinolytic therapy in acute myocardial infarction (AMI) is counter to a large volume of literature1-4 (see...
Primary PTCA vs. Fibrinolytic...
06/19/2008
Cath Lab Digest

Advertisement

Advertisement

Advertisement